Sun Pharma shares rise nearly 3% after Q3 profit beats estimates. What should investors do?
Sun Pharma reported a 15% YoY rise in Q3FY25 profit to Rs 2,903 crore, surpassing estimates. Revenue grew 10% to Rs 13,675.5 crore, driven by domestic and emerging markets. API sales rose 22%, while ...
Economic Survey Flags Detrimental Consequences Of Overwork Amid 70-90 Hour Workweek Debate
As the debate over long work hours gains momentum, the Economic Survey 2024-25 has cautioned against the detrimental impact of excessive working hours on mental health and productivity. Citing global ...